Literature DB >> 1902446

Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.

R Yanagihara1, A B Ajdukiewicz, V R Nerurkar, R M Garruto, D C Gajdusek.   

Abstract

We report the detection of human T-lymphotropic virus type I (HTLV-I) genomic sequences by polymerase chain reaction in lymphocyte cultures of three unrelated native Solomon Islanders, including a patient with HTLV-I myeloneuropathy, residing in widely separated regions. In addition, we have isolated HTLV-I from T-cell lines derived from two of these individuals. Virus-specific proteins of 15, 19, 24, 46 and 53 kilodaltons were detected by immunofluorescence and Western immunoblot, using serum from a Colombian patient with HTLV-I myeloneuropathy, sera from HTLV-I-infected rabbits, and monoclonal and polyclonal antibodies against HTLV-I gag and env gene products. Amplification of HTLV-I gag, pol and env sequences by polymerase chain reaction confirmed that the viral isolates were HTLV-I, not HTLV-II. Our data clearly demonstrate that HTLV-I does exist in Melanesia. Although the Solomon Islands viral isolates resemble prototype strains of HTLV-I, we believe they represent variants of HTLV-I, particularly in the light of our recent isolation of an HTLV-I variant from Papua New Guinea. Nucleotide sequence analysis of these viral strains, now in progress, should clarify the molecular epidemiology and phylogeny of HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902446      PMCID: PMC5918397          DOI: 10.1111/j.1349-7006.1991.tb01835.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  Isolation of HTLV-I from members of a remote tribe in New Guinea.

Authors:  R Yanagihara; R M Garruto; M A Miller; M Leon-Monzon; P P Liberski; D C Gajdusek; C L Jenkins; R C Sanders; M P Alpers
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

2.  HTLV-1 myeloneuropathy in the Solomon Islands.

Authors:  A Ajdukiewicz; R Yanagihara; R M Garruto; D C Gajdusek; S S Alexander
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

3.  High prevalence of serum antibody against human T cell leukemia virus type I (HTLV-I) among the Bismam Asmat population (Indonesian New Guinea).

Authors:  M C Re; M Tommaseo; G Furlini; M La Placa
Journal:  AIDS Res Hum Retroviruses       Date:  1989-10       Impact factor: 2.205

4.  High prevalence of human T-lymphotropic virus type I infection in isolated populations of the Western Pacific region confirmed by Western immunoblot.

Authors:  R M Garruto; M Slover; R Yanagihara; C A Mora; S S Alexander; D M Asher; P Rodgers-Johnson; D C Gajdusek
Journal:  Am J Hum Biol       Date:  1990       Impact factor: 1.937

5.  Antibodies to HTLV-I in populations of the southwestern Pacific.

Authors:  D M Asher; J Goudsmit; K L Pomeroy; R M Garruto; M Bakker; S G Ono; N Elliot; K Harris; H Askins; Z Eldadah
Journal:  J Med Virol       Date:  1988-12       Impact factor: 2.327

6.  HTLV-I antibodies in Papua New Guinea.

Authors:  D V Babona; G T Nurse
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

7.  Isolation and characterization of HTLV-I from symptomatic family members with tropical spastic paraparesis (HTLV-I encephalomyeloneuropathy).

Authors:  G McKhann; C J Gibbs; C A Mora; P E Rodgers-Johnson; P P Liberski; W J Gdula; V Zaninovic
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

8.  Human T-lymphotropic virus type I infection in the Solomon Islands.

Authors:  R Yanagihara; A B Ajdukiewicz; R M Garruto; E R Sharlow; X Y Wu; O Alemaena; H Sale; S S Alexander; D C Gajudusek
Journal:  Am J Trop Med Hyg       Date:  1991-02       Impact factor: 2.345

9.  Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.

Authors:  R Yanagihara; C L Jenkins; S S Alexander; C A Mora; R M Garruto
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

10.  Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.

Authors:  E P Reddy; M Sandberg-Wollheim; R V Mettus; P E Ray; E DeFreitas; H Koprowski
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

View more
  5 in total

Review 1.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.

Authors:  A Gessian; R Yanagihara; G Franchini; R M Garruto; C L Jenkins; A B Ajdukiewicz; R C Gallo; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.

Authors:  I Bastian; J Gardner; D Webb; I Gardner
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

5.  HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey.

Authors:  K Yamaguchi; T Inaoka; R Ohtsuka; T Akimichi; T Hongo; T Kawabe; M Nakazawa; M Futatsuka; K Takatsuki
Journal:  Jpn J Cancer Res       Date:  1993-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.